Clinical Trials Directory

Trials / Unknown

UnknownNCT04510870

Iron Deficiency as an Ignored Cause of Infertility

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
62 (estimated)
Sponsor
Dextra Fertility Clinic · Academic / Other
Sex
Female
Age
18 Years – 42 Years
Healthy volunteers
Not accepted

Summary

Iron deficiency may play a critical role in human infertility, oocyte quality and may even play a role in endometrial receptivity. By correcting iron deficiency, low ferritin values, in infertile women with intravenous iron supplementation, embryo quality and pregnancy rates may improve. The main objective is to evaluate the effect of intravenous iron supplementation on embryo quality (number of good quality blastocysts). Randomized, double blind, parallel group, cross-over study of ferric carboxymaltose compared to placebo (NaCl infusion).

Conditions

Interventions

TypeNameDescription
DRUGFerric Carboxymaltose InjectionInfusion prior the start of IVF/ICSI cycle. Dosing according to the summary of product characteristics (SmPC) chart. Placebo infusion before frozen embryo transfer if needed.
DRUGNaCl infusionPlacebo infusion prior the start of IVF/ICSI cycle. Ferric Carboxymaltose infusion before frozen embryo transfer if needed. Dosing according to the summary of product characteristics (SmPC) chart.

Timeline

Start date
2020-08-17
Primary completion
2021-12-31
Completion
2022-02-28
First posted
2020-08-12
Last updated
2020-08-12

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT04510870. Inclusion in this directory is not an endorsement.